Gene Query: MRPL10

Dataset Description Geneva Score
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 35.67
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 29.81
Unique features and clinical importance of acute alloreactive immune responses 27.52
Gene expression signatures of innate lymphoid cells from human blood 26.58
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 19.67
Single-nucleotide-resolution mapping of HBV promoters using CAGE 18.42
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 18.08
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 18.08
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 17.25
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 17.25
Patient-derived luminal breast cancer xenografts with progestins 16.78
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 16.78
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 16.63
Cleavage Factor Im as a key regulator of 3’ UTR length 15.57
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 13.72
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 13.3
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 13.3
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 13.23
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 12.47
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 12.31
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 12.3
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 12.04
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 11.25
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 11.25
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 10.88
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 10.47
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 10.34
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.0
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 9.94
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 9.94
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 9.94
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 9.94
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 9.87
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.83
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 9.79
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.73
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.73
Ectoderm specification of H1 human embryonic stem cells 9.71
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.7
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 9.44
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 9.35
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 9.22
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 9.16
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.06
Stem and effector CD8 T-cells from human cancers 8.98
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 8.98
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 8.95
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 8.91
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.75
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.63
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 8.52
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.44
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.43
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.34
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.28
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 8.12
Impact of dieldrin on transcription in Jurkat T cells 8.12
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.11
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 8.07
NRDE2 negatively regulates nuclear exosome functions 8.06
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 8.04
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 8.01
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 8.0
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 7.82
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.74
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.74
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 7.72
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.66
RNA-seq differential expression studies: more sequence, or more replication? 7.65
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.64
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 7.63
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.61
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 7.6
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 7.6
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 7.58
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.46
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 7.45
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 7.45
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.43
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 7.39
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.39
KLF6-dependent transcription in renal cancer cells 7.36
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.3
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.3
Global analysis of enhancer targets: Mosaic-seq 7.28
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.21
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 7.19
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 7.08
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 7.07
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 7.02
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 7.0
Energy Metabolism during Anchorage-Independence 6.94
m6A-dependent regulation of messenger RNA stability 6.87
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 6.82
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 6.81
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 6.75
Survival of pancreatic cancer cells lacking KRAS function 6.73
Evolution of a transcriptional regulator from a transmembrane nucleoporin 6.69
RNA-seq in HepG2 and IMR90 cells 6.69
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.6
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 6.6
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.55
CROP-Seq in Primary Human T Cells 6.53
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.51
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.51
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 6.41
The role of FAM46C in myeloma cells [sequencing] 6.4
The role of FAM46C in myeloma cells 6.4
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 6.35
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 6.34
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 6.34
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.33
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.29
Seletive inhibition of CDK9 in DLBCL cell lines 6.26
RNA-seq analysis of RALD iPSCs after in vitro differentiation 6.25
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 6.25
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.25
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.21
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6.18
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.13
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 6.12
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 6.12
EWSR1 influences alternative splicing through direct and indirect mechanisms 6.11
Transcriptomic analyssis following EHMT1/2 inhibition 6.09
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 6.05
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 6.02
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 6.02
Differentiation enhances Zika virus infection in neuronal brain cells 5.98
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 5.97
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.97
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.95
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.95
Dtx3L and Androgen Signaling in Prostate Cancer 5.95
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.93
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.92
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.92
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 5.91
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.88
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.88
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.88
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 5.87
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.82
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.81
mRNA expression profile of Lymphocytes 5.81
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.81
RNA-seq of IL-4 stimulated human keratinocytes 5.77
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 5.75
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 5.75
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.75
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.7
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.68
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.68
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 5.67
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.67
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 5.62
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 5.62
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.62
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 5.6
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 5.57
RNA-seq of human aneuploid cell lines with Trisomy 21 5.57
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.57
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.56
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.56
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 5.52
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 5.52
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 5.46
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.43
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 5.4
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.38
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 5.34
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 5.34
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 5.34
scRNASeq analysis of cycling cardiomyocytes 5.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.32
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.32
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.32
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.31
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 5.3
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.29
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 5.29
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.28
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 5.24
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.18
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 5.17
In situ CAPTURE of chromatin interactions by biotinylated dCas9 5.17
PRDM1 inhibits proliferation of human colon cancer organoids 5.15
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 5.14
Differentially expressed vascular development genes for iPSC-ECs from CDI 5.11
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 5.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 5.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 5.1
Genome wide expression change in LCC2 and MCF-7 cells 5.1
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 5.09
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.09
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 5.08
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.08
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.08
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 5.03
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.02
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 5.0
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.98
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 4.96
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.94
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 4.92
Active translatome profiling with RiboLace in MCF7 cells 4.92
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 4.88
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 4.87
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 4.87
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.83
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.81
High-throughput sequencing of pluripotent cells 4.8
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.8
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.74
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.74
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.73
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 4.72
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 4.69
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.68
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.68
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 4.67
Gene expression profile in breast cancer cell lines using RNA sequencing 4.66
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.66
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 4.59
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 4.59
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.5
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.49
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.49
H1609088 Human RNA-Sequencing 4.48
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.47
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.47
Global expression profiles in cardiac progenitor cells generated by ISX-9 4.46
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 4.46
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.44
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.4
Biological effect of chronic mistranslation in mammalian cells 4.37
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.37
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.35
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 4.32
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 4.3
hnRNP C is a key regulator of protein synthesis in mitosis 4.29
Neurofibroma 4.28
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 4.28
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.23
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.23
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 4.2
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 4.18
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.18
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.17
DIGIT regulates endoderm differentiation of human embryonic stem cells 4.15
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.14
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.11
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.09
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.05
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.03
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.03
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.01
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.99
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.98
Co-regulation of splicing by Rbfox1 and hnRNP M 3.98
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.95
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.91
RNA-Seq from human ILC transitional populations 3.9
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.9
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.85
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.83
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.82
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 3.81
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.79
RNA-seq analysis of BAP1-depleted uveal melanoma cells 3.74
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.74
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.73
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 3.7
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.7
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.69
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.67
Transcriptional effect of ETV1 knockdown in melanoma cells 3.64
Effect of from Human Umbilical Vein Endothelial Cells 3.63
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.57
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.57
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.54
Role of COP1 on MAP kinase transcriptional output in melanoma 3.53
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.53
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.51
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 3.5
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.49
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.48
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.45
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.45
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.41
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 3.39
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.39
RNA-seq of naive and primed ES cells (NHSM) 3.38
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.37
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.37
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.37
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.37
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.35
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.33
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.31
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.23
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.21
Regulating Interleukin-2 activity with engineered receptor signaling clamps 3.21
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.19
Gene expression analysis of breast cancer cell-lines 3.19
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.19
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.18
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.18
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.18
RNA editing in nascent RNA affects pre-mRNA splicing 3.14
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.1
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.1
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.09
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.05
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.02
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 3.0
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.99
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.99
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.97
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.97
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.92
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.84
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.81
Differential gene expression profiles in imatinib-resistant cell lines 2.8
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.79
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.77
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.77
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.76
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.75
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.71
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.7
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.69
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.66
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.61
TT-Seq captures the human transient transcriptome 2.59
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.58
Controlling for gene expression changes in transcription factor protein networks. 2.58
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 2.57
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.56
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 2.53
CD73 knockdown effect in pancreatic cancer cell lines 2.51
Single cell transcriptome of peritoneal cells 2.51
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.51
Determining mRNA half-lives on a transcriptome-wide scale 2.51
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.5
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.49
Targeting MTHFD2 in Acute Myeloid Leukemia 2.47
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.42
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.41
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.4
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.39
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.32
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.29
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.27
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 2.26
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.26
Expression profiling of MCF-7 cells with treatment of TCDD 2.26
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.25
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.22
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.2
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.16
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.16
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 2.11
Illumina Total RNA-seq in HeLa 2.09
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.06
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.03
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.03
miRNAs affected by antagomiR-17 treatment 1.96
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.95
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.93
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 1.92
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.9
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.9
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.87
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.87
SLAM-seq for K562 endogenous mRNA decay 1.86
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.84
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.83
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.82
A549 cell transcriptome responses to infection with H7N9 influenza virus 1.81
O-glcnAc reprograms cellular energetics 1.8
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.78
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.76
Single-cell analysis of human kidney organoids 1.73
K562 polyA RNA-Seq 1.66
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.66
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.65
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.64
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.6
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.6
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.6
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.59
Ribosomal protein RPL26 is the principal target of UFMylation 1.56
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.55
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.54
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.54
RNAseq of cell lines with knocked in ESR1 mutations 1.51
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.49
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.46
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.46
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.46
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.45
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.45
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.43
Identification of global XBP1s target gene expression in human prostate cancer cells 1.43
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.42
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 1.4
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.35
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.3
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.3
Transcriptome of EBV-infected gastric cancer cell lines 1.3
Interaction between mitoNEET and NAF-1 in cancer cells 1.28
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.24
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.22
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.21
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.18
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.16
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.11
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.1
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.1
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.09
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.08
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.07
Loss of CREBBP results in gene expression repression in lymphoma cells 1.06
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.06
Comparative Analysis of Cas9 Activators Across Multiple Species 1.04
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.04
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.02
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.02
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.02
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.01
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.99
Hepatic transcriptome of pediatric hepatoblastoma. 0.98
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.98
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.98
Human Treg NaCl stimulation 0.97
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.96
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.96
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.92
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.88
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.88
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.84
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.82
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.81
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.78
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.77
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.76
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.76
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.76
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.72
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.71
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.7
mRNA expression profile of Lymphocytes by high-throuput sequencing 0.7
Fusion discovery in breast cancer cell line 0.7
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.69
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.59
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.56
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.55
High-resolution comparative analysis of great ape genomes 0.53
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.53
Transcriptome of activated human and mouse MAIT cells 0.52
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.49
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.49
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.49
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.48
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.46
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.42
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.41
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.41
Global transcriptome analysis of WT versus HEB-/- hESCs 0.41
Finding missing proteins from epigenetically manipulated human cells 0.4
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.38
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.35
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.34
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.3
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.3
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.25
MARS Seq data from human cortical organoids 0.24
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.23
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.23
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.23
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.23
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.19
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.18
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.15
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.14
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.14
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.12
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.1
Identification of a LIF-responsive replication-competent human β cell 0.09
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.04
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.04
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.03
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation